PRL and breast cancer: The candidate target genes were significantly enriched for the breast cancer, gastric cancer, hepatocellular carcinoma, nicotine addiction, neurodegeneration-multiple diseases, long-term depression, basal cell carcinoma, long-term potentiation, amphetamine addiction, and prolactin signaling pathways (see Supplementary File 3D).